Elite Pharmaceuticals Inc  

(Public, OTCBB:ELTP)   Watch this stock  
Find more results for OTC:ELTP
-0.010 (-2.96%)
Sep 19 - Close
OTCBB data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.32 - 0.34
52 week 0.09 - 0.97
Open 0.34
Vol / Avg. 1.86M/1.41M
Mkt cap 186.77M
P/E     -
Div/yield     -
EPS -0.19
Shares 574.67M
Beta 0.46
Inst. own 0%
Sep 9, 2014
Elite Pharmaceuticals Inc at Rodman & Renshaw Global Investment Conference
Jul 1, 2014
Q4 2014 Elite Pharmaceuticals Inc Earnings Call
Jun 30, 2014
Q4 2014 Elite Pharmaceuticals Inc Earnings Release

Key stats and ratios

Q2 (Jun '14) 2014
Net profit margin -378.92% -2098.83%
Operating margin -381.45% -114.83%
EBITD margin - -103.94%
Return on average assets -73.13% -544.96%
Return on average equity - -
Employees 38 -
CDP Score - -


165 Ludlow Avenue
United States - Map
+1-201-7502646 (Phone)
+1-201-7502755 (Fax)

Website links


Elite Pharmaceuticals, Inc. (Elite) is a specialty pharmaceutical company principally engaged in the development and manufactures of oral, controlled-release products, using technology and the development and manufacture of generic pharmaceuticals. Elite has four products: Phentermine 37.5 milligram tablets, Methadone 10 milligram tablets, Lodrane D Immediate Release capsules and Hydromorphone Hydrochloride 8 milligram tablets. During the fiscal years ended March 31, 2012 (Fiscal 2011), the Company manufactured and sold Lodrane 24 and Lodrane 24D (the Lodrane Extended Release Products). The Company has a pipeline of additional generic drug candidates under active development, including, without limitation, ELI-154, a once-a-day oxycodone product and ELI-216, an abuse resistant oxycodone product which utilizes the Company�s propriety formulation for abuse resistant products utilizing the pharmacological approach (Elite�s Abuse Resistant Technology).

Officers and directors

Jerry I. Treppel Chairman of the Board
Age: 59
Nasrat Hakim President, Chief Executive Officer, Director
Age: 53
Carter J. Ward CPA Chief Financial Officer, Treasurer, Secretary
Age: 49
Ashok G. Nigalaye Ph.D. Chief Scientific Officer, Director
Age: 62
Jeenarine Narine Director
Age: 63
Barry H. Dash Ph.D. Independent Director
Age: 82
Jeffrey A. Whitnell Independent Director
Age: 58